Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1

Interventions

Cisplatin 4Radiotherapy 3Radiation 3Amifostine 2pegfilgrastim 1Vaccinium myrtillus extract 1Tramadol 1Surgical Procedures, Operative 1Selenomethionine 1Radiotherapy, Intensity-Modulated 1Paclitaxel 1Neck Dissection 1Lysine 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1Fibroblast Growth Factor 7 1Doxepin 1Docetaxel 1Carboplatin 1CBLB502 1Buprenorphine 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × CBLB502 × Other × Clear all
NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡